United Orthopedic Corporation Statistics
United Orthopedic Corporation (4129) Stock Statistics & Valuation Metrics
Total Valuation
United Orthopedic Corporation has a market cap or net worth of TWD 7.01B. The enterprise value is TWD 11.33B.
- Market Cap
- TWD 7.01B
- Enterprise Value
- TWD 11.33B
Share Statistics
United Orthopedic Corporation has 96,437,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 96,437,650
- Owned by Insiders
- ―
- Owned by Institutions
- 0.50%
Financial Efficiency
United Orthopedic Corporation’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.77%.
- Return on Equity (ROE)
- 0.14
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.77%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 9.82M
- Profits Per Employee
- 976.56K
- Employee Count
- 576
- Asset Turnover
- 0.72
- Inventory Turnover
- 0.61
Valuation Ratios
The current PE Ratio of United Orthopedic Corporation is 12.71. United Orthopedic Corporation’s PEG ratio is 1.19.
- PE Ratio
- 12.71
- PS Ratio
- 1.16
- PB Ratio
- 1.80
- Price to FCF
- -83.34
- Price to Operating Cash Flow
- 9.71
- PEG Ratio
- 1.19
Income Statement
In the last 12 months, United Orthopedic Corporation had revenue of 5.66B and earned 562.50M in profits. Earnings per share was 5.83.
- Revenue
- 5.66B
- Gross Profit
- 4.40B
- Operating Income
- 740.72M
- Pretax Income
- 756.40M
- Net Income
- 562.50M
- EBITDA
- 1.28B
- Earnings Per Share (EPS)
- 5.83
Cash Flow
In the last 12 months, operating cash flow was 725.63M and capital expenditures -809.75M, giving a free cash flow of -84.12M billion.
- Operating Cash Flow
- 725.63M
- Free Cash Flow
- -84.12M
- Free Cash Flow per Share
- -0.87
Dividends & Yields
United Orthopedic Corporation pays an annual dividend of ―, resulting in a dividend yield of 6.19%
- Dividend Per Share
- ―
- Dividend Yield
- 6.19%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.20%
- Earnings Yield
- 7.83%
Stock Price Statistics
- Beta
- 0.37
- 52-Week Price Change
- -41.84%
- 50-Day Moving Average
- 80.16
- 200-Day Moving Average
- 89.60
- Relative Strength Index (RSI)
- 29.91
- Average Volume (3m)
- 243.74K
Important Dates
United Orthopedic Corporation upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
United Orthopedic Corporation as a current ratio of 1.72, with Debt / Equity ratio of 50.25%
- Current Ratio
- 1.72
- Quick Ratio
- 0.89
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- 1.09
- Interest Coverage Ratio
- 16.12
Taxes
In the past 12 months, United Orthopedic Corporation has paid 184.93M in taxes.
- Income Tax
- 184.93M
- Effective Tax Rate
- 0.24
Enterprise Valuation
United Orthopedic Corporation EV to EBITDA ratio is 6.79, with an EV/FCF ratio of -104.52.
- EV to Sales
- 1.45
- EV to EBITDA
- 6.79
- EV to Free Cash Flow
- -104.52
- EV to Operating Cash Flow
- 12.12
Balance Sheet
United Orthopedic Corporation has TWD 579.93M in cash and marketable securities with TWD 2.36B in debt, giving a net cash position of -TWD 1.78B billion.
- Cash & Marketable Securities
- TWD 579.93M
- Total Debt
- TWD 2.36B
- Net Cash
- -TWD 1.78B
- Net Cash Per Share
- -TWD 18.47
- Tangible Book Value Per Share
- TWD 35.22
Margins
Gross margin is 78.12%, with operating margin of 11.55%, and net profit margin of 9.11%.
- Gross Margin
- 78.12%
- Operating Margin
- 11.55%
- Pretax Margin
- 12.10%
- Net Profit Margin
- 9.11%
- EBITDA Margin
- 21.38%
- EBIT Margin
- 11.52%
Analyst Forecast
The average price target for United Orthopedic Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 18.91%
- EPS Growth Forecast
- 10.75%
